Showing results (21-30 of 102) with videos related to
Sort By:
Pageof 11
Clinical Pharmacology in Drug Development|May 7, 2019
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Food Effect of Danirixin Hydrobromide Tablets in Japanese Healthy Elderly ParticipantsTakayuki Iida, Yuki Matsuzawa, Hirofumi Ogura, et al.The Journal of Thoracic and Cardiovascular Surgery|August 29, 2006
Failure of surface-modified bypass circuits to improve platelet function during pediatric cardiac surgeryPaul M Kirshbom, Bruce E Miller, Kathy Spitzer, et al.Respiratory Medicine|March 8, 2011
Evaluation of exhaled breath condensate pH as a biomarker for COPDWilliam MacNee, Stephen I Rennard, John F Hunt, et al.Respiratory Research|June 14, 2020
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trialAili L Lazaar, Bruce E Miller, Alison C Donald, et al.European Journal of Clinical Investigation|June 19, 2012
Dysregulated adipokine metabolism in chronic obstructive pulmonary diseaseMarie-Kathrin Breyer, Erica P A Rutten, Nicholas W Locantore, et al.Journal of Patient Experience|February 6, 2023
The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory InfectionsRuth Tal-Singer, Bruce E Miller, Jean M Rommes, et al.Anesthesia and Analgesia|October 23, 2003
Tissue factor-activated thromboelastograms in children undergoing cardiac surgery: baseline values and comparisonsBruce E Miller, Nina A Guzzetta, Steven R Tosone, et al.Journal of Clinical Pharmacology|November 18, 2011
An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary diseaseDavid A Lomas, David A Lipson, Bruce E Miller, et al.American Journal of Respiratory and Critical Care Medicine|July 2, 2015
Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lungJohn G Yonchuk, Edwin K Silverman, Russell P Bowler, et al.BMC Pharmacology & Toxicology|June 21, 2015
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjectsBruce E Miller, Sunil Mistry, Kevin Smart, et al.Pageof 11